CRISPR-Cas in Streptococcus pyogenes

Le Rhun, Anaïs; Escalera-Maurer, Andrés; Bratovič, Majda; Charpentier, Emmanuelle

doi:10.1080/15476286.2019.1582974

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

CRISPR-Cas in Streptococcus pyogenes

MPS-Authors

Le Rhun, Anaïs
Max Planck Unit for the Science of Pathogens, Max Planck Society;

Escalera-Maurer, Andrés
Max Planck Unit for the Science of Pathogens, Max Planck Society;

Bratovič, Majda
Max Planck Unit for the Science of Pathogens, Max Planck Society;

Charpentier, Emmanuelle
Max Planck Unit for the Science of Pathogens, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Le Rhun, A., Escalera-Maurer, A., Bratovič, M., & Charpentier, E. (2019). CRISPR-Cas in Streptococcus pyogenes. RNA Biology, 16(4), 380-389. doi:10.1080/15476286.2019.1582974.

引用: https://hdl.handle.net/21.11116/0000-0008-744B-2

要旨

The discovery and characterization of the prokaryotic CRISPR-Cas immune system has led to a revolution in genome editing and engineering technologies. Despite the fact that most applications emerged after the discovery of the type II-A CRISPR-Cas9 system of Streptococcus pyogenes, its biological importance in this organism has received little attention. Here, we provide a comprehensive overview of the current knowledge about CRISPR-Cas systems from S. pyogenes. We discuss how the interplay between CRISPR-mediated immunity and horizontal gene transfer might have modeled the evolution of this pathogen. We review the current literature about the CRISPR-Cas systems present in S. pyogenes (types I-C and II-A), and describe their distinctive biochemical and functional features. Finally, we summarize the main biotechnological applications that have arisen from the discovery of the CRISPR-Cas9 system in S. pyogenes.